Latest News

Pancreas (Getty Images)

Protein degradation strategy offers hope in cancer therapy

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A University of California, Riverside team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development. The team reports in the Proceedings of the National Academy of Sciences that it...
By Iqbal Pittalwala |
Ernest Martinez looking at petri dish in his lab

Identification of new signaling pathway advances cancer research

A UC Riverside-led study focusing on an oncoprotein called MYC has discovered a new MYC signaling mechanism that is deregulated in cancer cells. This mechanism, called MYC lysine-acetylation, activates specific genes that make mammary cells malignant and drives the tumor-promoting functions of MYC, including the ability of cancer cells to survive and proliferate even without...
By Iqbal Pittalwala |
cancer patient receiving treatment

Partnership between UCR and City of Hope aims to increase diversity in cancer research

A multiyear cancer-research project, stemming from a newly established partnership between the University of California, Riverside, and the City of Hope – Comprehensive Cancer Center (CoH-CCC), has received funding from the National Cancer Institute (NCI) of the National Institutes of Health to develop collaborations, resources, and training programs aimed at reducing disparities in cancer research...
By Iqbal Pittalwala |
Let us help you with your search